Tianyi Hu

1.7k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Tianyi Hu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Tianyi Hu has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Tianyi Hu's work include RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers) and HER2/EGFR in Cancer Research (2 papers). Tianyi Hu is often cited by papers focused on RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers) and HER2/EGFR in Cancer Research (2 papers). Tianyi Hu collaborates with scholars based in United States, Austria and United Kingdom. Tianyi Hu's co-authors include Robert Blelloch, Cassandra D. Belair, Lawrence Fong, Mauro Poggio, Ursula E. Lang, Chien-Chun Steven Pai, Anthony Chang, Elizabeth Montabana, Qi Fu and Emma Burbridge and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

In The Last Decade

Tianyi Hu

10 papers receiving 1.3k citations

Hit Papers

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor... 2019 2026 2021 2023 2019 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianyi Hu United States 6 945 460 437 428 197 10 1.3k
Gonçalo Rodrigues Portugal 9 998 1.1× 344 0.7× 574 1.3× 546 1.3× 306 1.6× 11 1.7k
Mauro Poggio United States 3 780 0.8× 439 1.0× 366 0.8× 345 0.8× 193 1.0× 6 1.1k
Stefania Mazzoleni Italy 15 523 0.6× 434 0.9× 562 1.3× 259 0.6× 201 1.0× 22 1.3k
Manuela Silginer Switzerland 16 415 0.4× 289 0.6× 344 0.8× 174 0.4× 155 0.8× 31 1.0k
Horacio Soto United States 18 661 0.7× 697 1.5× 759 1.7× 414 1.0× 148 0.8× 28 1.7k
Niko P. Bretz Germany 13 897 0.9× 273 0.6× 286 0.7× 457 1.1× 44 0.2× 14 1.2k
Rajender Nandigama Germany 12 426 0.5× 226 0.5× 500 1.1× 193 0.5× 280 1.4× 21 1.3k
Malgorzata Anna Zal United States 10 336 0.4× 563 1.2× 246 0.6× 264 0.6× 87 0.4× 26 959
Marina Kochetkova Australia 19 534 0.6× 331 0.7× 595 1.4× 203 0.5× 76 0.4× 26 1.1k
Dmitriy Kedrin United States 15 502 0.5× 270 0.6× 569 1.3× 208 0.5× 281 1.4× 21 1.3k

Countries citing papers authored by Tianyi Hu

Since Specialization
Citations

This map shows the geographic impact of Tianyi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyi Hu more than expected).

Fields of papers citing papers by Tianyi Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyi Hu. The network helps show where Tianyi Hu may publish in the future.

Co-authorship network of co-authors of Tianyi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyi Hu. A scholar is included among the top collaborators of Tianyi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyi Hu. Tianyi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Zhang, Man, Hao Feng, Yahui Huang, et al.. (2025). Modified CD40L‐Activated B‐Cell Proliferation Model for Validating the Suppressive Activity of CD40‐CD154 Pathway Inhibitors. Xenotransplantation. 32(1). e70029–e70029. 1 indexed citations
2.
Ghosh, Tanushree, Liewei L. Yan, Yuming Wang, et al.. (2025). ZNF574 is a quality control factor for defective ribosome biogenesis intermediates. Molecular Cell. 85(10). 2048–2060.e9. 1 indexed citations
3.
Poggio, Mauro, Tianyi Hu, Chien-Chun Steven Pai, et al.. (2019). Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Cell. 177(2). 414–427.e13. 1050 indexed citations breakdown →
4.
Belair, Cassandra D., et al.. (2019). High-throughput, Efficient, and Unbiased Capture of Small RNAs from Low-input Samples for Sequencing. Scientific Reports. 9(1). 2262–2262. 15 indexed citations
5.
Burbridge, Emma, Miguel Cavadas, Graeme P. Sullivan, et al.. (2018). iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. eLife. 7. 64 indexed citations
6.
Cavadas, Miguel, Emma Burbridge, Marina Badenes, et al.. (2018). Phosphorylation of iRhom2 Is Essential for Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE. SSRN Electronic Journal. 1 indexed citations
7.
Cavadas, Miguel, Emma Burbridge, Marina Badenes, et al.. (2017). Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE. Cell Reports. 21(3). 745–757. 82 indexed citations
8.
Hu, Zhonghua, Jun Zhao, Tianyi Hu, et al.. (2015). miR-501-3p mediates the activity-dependent regulation of the expression of AMPA receptor subunit GluA1. The Journal of Cell Biology. 208(7). 949–959. 56 indexed citations
9.
Hu, Zhonghua, Jun Zhao, Tianyi Hu, et al.. (2015). miR-501-3p mediates the activity-dependent regulation of the expression of AMPA receptor subunit GluA1. The Journal of General Physiology. 145(4). 1454OIA12–1454OIA12. 1 indexed citations
10.
Hu, Jian, Allen L. Ho, Liang Yuan, et al.. (2013). Neutralization of terminal differentiation in gliomagenesis. Proceedings of the National Academy of Sciences. 110(36). 14520–14527. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026